Articles tagged "Kidney transplantation"

2018 American Transplant Congress
CMV Mismatch Still Negatively Affects Patient and Graft Survival in the Era of CMV Prophylactic and Preemptive Therapy: A Paired Kidney Analysis
N. Leeaphorn,¹ N. Garg,² N. Thamcharoen,¹ E. Khankin,¹ F. Cardarelli,¹ M. Pavlakis.¹
¹Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA; ²Department of Medicine, Nephrology Division, University of Wisconsin School of Medicine, Madison, WI.
Background: The impact of CMV serostatus on kidney transplant outcomes in an era when CMV prophylactic and preemptive strategies are used routinely is not clearly…
2018 American Transplant Congress
Trends, Patterns, and Recipient Outcomes of Kidney Transplants from Older (>60) Living Donors. A UNOS Database Analysis
A. Riaz, O. Adebiyi, M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin.
Indiana University, Indianapolis.
Backgroud: The selection of older donors (>60 years) has become more common. Our aim was to analyze the recent national trends of such donors and…
2018 American Transplant Congress
Basiliximab Induction in HIV-Positive Renal Transplant Recipients Compared to an HIV-Negative Cohort
J. Schulte,¹ C. Richardson,¹ V. Stosor,² K. Cunningham,¹ C. D'Agostino,¹ C. Kane.¹
¹Pharmacy, Northwestern Memorial Hospital, Chicago; ²Infectious Diseases and Organ Transplantation, Northwestern Memorial Hospital, Chicago.
Purpose: There is an elevated risk of acute rejection in HIV+ renal transplant recipients and continued evaluation of the most appropriate induction therapy remains. Use…
2018 American Transplant Congress
Variation in Post-Transplant Opiate Prescribing Patterns across Transplant Centers
A. Mathur, D. Ubl, J. Harbell, K. Croome, C. Taner, J. Heimbach, A. Moss, E. Habermann.
Mayo Clinic, Rochester, Phoenix, Jacksonville.
Background: Excess opiate prescribing has led to an epidemic, and evidence to guide abdominal transplant practice is lacking. We aimed to identify variation in opiate…
2018 American Transplant Congress
How Safe is Crossing the ABO Blood Group Barrier? A Meta-Analysis to Determine the Additive Risk of ABO-Incompatible Kidney Transplantation
A. de Weerd, M. Betjes.
Nephrology and Kidney Transplantation, Erasmus Medical Center, Rotterdam, Netherlands.
Background ABO blood group-incompatible (ABOi) kidney transplantation is considered a safe procedure, with non-inferior outcomes in large cohort studies. Its contribution to living kidney transplantation…
2018 American Transplant Congress
Do Reconstruction Techniques for Two Renal Arteries Affect Long-Term Graft Survival after Living Donor Renal Transplantation?
S. Yamanaga, P. Stock, M. Tavkol, S-.M. Kang.
Transplant Surgery, UCSF, San Francisco, CA.
Background: Living donor kidneys with two arteries can be revascularized using various techniques depending on anatomy. We hypothesized that the revascularization technique could impact long-term…
2018 American Transplant Congress
Estimated Impact of the Number of Simultaneous Offers on Kidney Delay and Discard
M. Mankowski,¹ S. Raghavan,³ C. Holscher,² M. Kosztowski,² D. Segev,² S. Gentry.⁴
¹King Abdullah University of Science and Technology, Thuwal, Saudi Arabia; ²Johns Hopkins University, Baltimore; ³University of Maryland, College Park; ⁴US Naval Academy, Annapolis.
Following local decline of a recovered kidney, making regional and national offers in larger simultaneous batches might decrease discards. We simulated varying batch sizes for…
2018 American Transplant Congress
The Advantage of Utilizing ABO and HLA Compatible Pairs in Kidney Paired Donation
A. Basu,¹ C. Kosberg,¹ H. Khamash,² M. Mai,³ M. Prieto,¹ C. Schinstock.¹
¹Nephrology and Hypertension, Mayo Clinic, Rochester, MN; ²Nephrology and Hypertension, Mayo Clinic, Scottsdale, AZ; ³Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL.
BACKGROUND: Kidney paired donation (KPD) programs are mainly used to facilitate transplantation for candidates with ABO or HLA incompatible living donors. However, the benefit of…
2018 American Transplant Congress
Pancreas Transplant Recipients with End-Stage Renal Disease Benefit from Kidney Transplantation
Y. Tang, Z. Zhu, S. Huang, Z. Zhang, W. Ju, Z. Guo, X. He, G. Chen.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Background: End-stage renal disease (ESRD) has been shown after pancreas transplant alone (PTA), however, the benefit of kidney transplantation (KT) in PTA recipients with ESRD…
2018 American Transplant Congress
The Living Donor Lost Wages Trial: Study Rationale, Protocol, and Update
J. Rodrigue,¹ M. Pavlakis,¹ A. Evenson,¹ A. Fleishman,¹ M. Carroll,¹ D. Mandelbrot,² P. Baliga,³ D. Howard,⁴ J. Schold.⁵
¹Beth Israel Deaconess Medical Center, Boston, MA; ²University of Wisconsin, Madison, WI; ³Medical University of South Carolina, Charleston, SC; ⁴Emory University, Atlanta, GA; ⁵Cleveland Clinic, Cleveland, OH.
Living donor kidney transplantation (LDKT) is the optimal treatment for adults with renal failure. However, living kidney donation has declined in the past decade, particularly…